LIM Domain Only-2 (LMO2) Induces T-Cell Leukemia by Two Distinct Pathways

• Stephen Smith ,

  Contributed equally to this work with: Stephen Smith, Rati Tripathi

  Affiliation Division of Hematology/Oncology, Vanderbilt University Medical Center and the Tennessee Valley Healthcare System, Nashville, Tennessee, United States of America

  ⨯
• Rati Tripathi ,

  Contributed equally to this work with: Stephen Smith, Rati Tripathi

  Affiliation Division of Hematology/Oncology, Vanderbilt University Medical Center and the Tennessee Valley Healthcare System, Nashville, Tennessee, United States of America

  ⨯
• Charnise Goodings,

  Affiliation Division of Hematology/Oncology, Vanderbilt University Medical Center and the Tennessee Valley Healthcare System, Nashville, Tennessee, United States of America

  ⨯
• Susan Cleveland,

  Affiliation Division of Hematology/Oncology, Vanderbilt University Medical Center and the Tennessee Valley Healthcare System, Nashville, Tennessee, United States of America

  ⨯
• Elizabeth Mathias,

  Affiliation Division of Hematology/Oncology, Vanderbilt University Medical Center and the Tennessee Valley Healthcare System, Nashville, Tennessee, United States of America

  ⨯
• J. Andrew Hardaway,

  Affiliation Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• Natalina Elliott,

  Affiliation Division of Hematology/Oncology, Vanderbilt University Medical Center and the Tennessee Valley Healthcare System, Nashville, Tennessee, United States of America

  ⨯
• Yajun Yi,

  Affiliation Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• Xi Chen,

  Affiliation Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• James Downing,

  Affiliation Department of Pathology, St Jude Children's Research Hospital, Memphis, Tennessee, United States of America

  ⨯
• Charles Mullighan,

  Affiliation Department of Pathology, St Jude Children's Research Hospital, Memphis, Tennessee, United States of America

  ⨯
• Deborah A. Swing,

  Affiliation Mouse Cancer Genetics Program, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Lino Tessarollo,

  Affiliation Mouse Cancer Genetics Program, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Liqi Li,

  Affiliation National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Paul Love,

  Affiliation National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Nancy A. Jenkins,

  Affiliation The Methodist Hospital Research Institute, Houston, Texas, United States of America

  ⨯
• Neal G. Copeland,

  Affiliation The Methodist Hospital Research Institute, Houston, Texas, United States of America

  ⨯
• Mary Ann Thompson,

  Affiliation Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• Yang Du,

  Affiliation Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America

  ⨯
•  [ ... ],
• Utpal P. Davé

  * E-mail: utpal.dave@vanderbilt.edu

  Affiliation Division of Hematology/Oncology, Vanderbilt University Medical Center and the Tennessee Valley Healthcare System, Nashville, Tennessee, United States of America

  ⨯
• [ view all ]
• [ view less ]